Autoimmune Hemolytic Anemia

Common Name(s)

Autoimmune Hemolytic Anemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Autoimmune Hemolytic Anemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Autoimmune Hemolytic Anemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Autoimmune Hemolytic Anemia" returned 125 free, full-text research articles on human participants. First 3 results:

Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
 

Author(s): Kathleen Abadie, Kristen M Hege

Journal:

 

Rituximab is an emerging treatment for autoimmune hemolytic anemia. We report the case of a patient with a five-year complete hematologic response to a third course of treatment with rituximab. Cases of response to rituximab re-treatments have been reported, but none to our knowledge ...

Last Updated: 2 Jul 2014

Go To URL
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
 

Author(s): Rym Ennaifer, Myriam Cheikh, Hayfa Romdhane, Rania Hefaiedh, Houda Ben Nejma, Najet Bel Hadj

Journal: Tunis Med. 2014 Jan;92(1):42-3.

 

Last Updated: 2 Jun 2014

Go To URL
[Lower dose of rituximab in the treatment of elderly autoimmune hemolytic anemia].
 

Author(s): Xiaokun Zhang, Jie Sun

Journal: Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):236-8.

 

To explore the safety and efficacy of lower dose of rituximab in the treatment of elderly autoimmune hemolytic anemia (AIHA).

Last Updated: 26 Mar 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Autoimmune Hemolytic Anemia" returned 9 free, full-text review articles on human participants. First 3 results:

A case of recurrent autoimmune hemolytic anemia during remission associated with acute pure red cell aplasia and hemophagocytic syndrome due to human parvovirus B19 infection successfully treated by steroid pulse therapy with a review of the literature.
 

Author(s): Yasunobu Sekiguchi, Asami Shimada, Hidenori Imai, Mutsumi Wakabayashi, Keiji Sugimoto, Noriko Nakamura, Tomohiro Sawada, Norio Komatsu, Masaaki Noguchi

Journal:

 

The patient was a 47-year-old man diagnosed as having autoimmune hemolytic anemia (AIHA) in April 2011. He also had a congenital chromosomal abnormality, a balanced translocation. Treatment with prednisolone (PSL) 60 mg/day resulted in resolution of the AIHA, and the treatment was ...

Last Updated: 26 Jun 2014

Go To URL
Immunotherapy treatments of warm autoimmune hemolytic anemia.
 

Author(s): Bainan Liu, Wangang Gu

Journal: Clin. Dev. Immunol.. 2013 ;2013():561852.

 

Warm autoimmune hemolytic anemia (WAIHA) is one of four clinical types of autoimmune hemolytic anemia (AIHA), with the characteristics of autoantibodies maximally active at body temperature. It produces a variable anemia-sometimes mild and sometimes severe. With respect to the absence ...

Last Updated: 9 Oct 2013

Go To URL
[Rituximab for the treatment of refractory autoimmune hemolytic anemia and pseudothrombocytopenia in infant: a case report and literature review].
 

Author(s): Wen-bin An, Ye Guo, Shu-chun Wang

Journal: Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):957-9.

 

Last Updated: 31 Jan 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Immunopathology of Autoimmune Hemolytic Anemia
 

Status: Recruiting

Condition Summary: Autoimmune Hemolytic Anemia

 

Last Updated: 5 Jun 2014

Go to URL
Sirolimus for Autoimmune Disease of Blood Cells
 

Status: Recruiting

Condition Summary: Autoimmune Pancytopenia; Autoimmune Lymphoproliferative Syndrome (ALPS); Evans Syndrome; Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune; Autoimmune Neutropenia; Lupus Erythematosus, Systemic; Inflammatory Bowel Disease; Rheumatoid Arthritis

 

Last Updated: 17 Oct 2014

Go to URL